Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue milestone.
Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Colgate-Palmolive. The Motley Fool has a disclosure policy.
JesterAI cannot own stocks and so it has no positions in any stocks mentioned. The Motley Fool has positions in and recommends Colgate-Palmolive. The Motley Fool has a disclosure policy.
Shares of Colgate-Palmolive (NYSE: CL) pulled back today after the household products giant missed the mark on the top line in its fourth-quarter earnings report and gave a weak outlook.
Toothpaste and toothbrush giant Colgate-Palmolive hit a full-year revenue ... and make sure their analysis is clear and in no way misleading or deceptive. To further protect the integrity of ...
Colgate-Palmolive Q4 EPS of $0.91 beat estimates. FY25 sales growth forecast of 3-5% aligns with long-term goals. Get Wall Street's Hottest Chart Every Morning CL reported fourth-quarter earnings ...
In this article, we are going to take a look at where Colgate-Palmolive Company (NYSE:CL) stands against other best defensive stocks to buy right now. A notable event influencing current market ...
NEW YORK, January 17, 2025--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2024 fourth quarter and full year earnings conference call on Friday, January 31, 2025 ...
The playboy star co-wrote and produced the layered satire about a Beverly Hills hairstylist in the midst of an existential ...
Loaded with biotin — an essential B vitamin that assists in keratin production — this $9 shampoo is designed to be gentle as it adds noticeable oomph to your ‘do. “This is the best shampoo I’ve ever ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results